Biodefense: Trends and challenges in combating biological warfare agents

Virulence

Volumn 4, Issue 8, 2013, Pages 740-744

  Tegos, George P ^a,b,c,d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biodefense pathogens; Biosensors; Biosurveillance; Immunotherapeutics; Light based therapeutics; Rapid diagnostics; Ribosome inactivating proteins.; Small RNA mediated discovery; Staphylococcal enterotoxins

Indexed keywords

INTERLEUKIN 1BETA; RIBOSOME INACTIVATING PROTEIN; TOXIN;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIOFILM; BIOLOGICAL WARFARE; BIOSENSOR; BIOSURVEILLANCE; DEFENSE MECHANISM; GENE EXPRESSION; GENETIC ENGINEERING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOTHERAPY; INCIDENCE; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; POLYMERASE CHAIN REACTION; TULAREMIA; BACTERIUM; BIODEFENSE PATHOGENS; BIOLOGICAL WARFARE AGENT; CIVIL DEFENSE; EDITORIAL; GENETIC PROCEDURES; IMMUNOTHERAPEUTICS; ISOLATION AND PURIFICATION; LIGHT-BASED THERAPEUTICS; METHODOLOGY; RAPID DIAGNOSTICS; RIBOSOME-INACTIVATING PROTEINS; SMALL RNA-MEDIATED DISCOVERY; STAPHYLOCOCCAL ENTEROTOXINS; VIRUS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS;

BIODEFENSE PATHOGENS; BIOSENSORS; BIOSURVEILLANCE; IMMUNOTHERAPEUTICS; LIGHT-BASED THERAPEUTICS; RAPID DIAGNOSTICS; RIBOSOME-INACTIVATING PROTEINS; SMALL RNA-MEDIATED DISCOVERY; STAPHYLOCOCCAL ENTEROTOXINS;

BACTERIA; BIOLOGICAL WARFARE AGENTS; BIOSENSING TECHNIQUES; CIVIL DEFENSE; HUMANS; TOXINS, BIOLOGICAL; VIRUSES;

EID: 84888410226     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.27170     Document Type: Article

References (28)

1. Levy BS, Sidel VW. Adverse health consequences of US Government responses to the 2001 terrorist attacks. Lancet 2011; 378:944-52; PMID:21890059; http://dx.doi.org/10.1016/S0140-6736(11)60970-7
2. Inglesby T. Straight talk with Tom Inglesby. Interview by Kevin Jiang. Nat Med 2013; 19:657; PMID:23744137; http://dx.doi.org/10.1038/nm0613-657
3. Matheny J, Mair M, Smith B. Cost/success projections for US biodefense countermeasure development. Nat Biotechnol 2008; 26:981-3; PMID:18779804; http://dx.doi.org/10.1038/nbt0908-981
4. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367:1035-44; PMID:22970946; http://dx.doi.org/10.1056/NEJMra1204699
5. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383-416; PMID:15831829; http://dx.doi.org/10.1128/CMR.18.2.383-416.2005
6. McGarvey PB, Huang H, Mazumder R, Zhang J, Chen Y, Zhang C, Cammer S, Will R, Odle M, Sobral B, et al. Systems integration of biodefense omics data for analysis of pathogen-host interactions and identification of potential targets. PLoS One 2009; 4:e7162; PMID:19779614; http://dx.doi.org/10.1371/journal.pone.0007162
7. Petsko GA. Biodefense versus bioterrorism. Genome Biol 2008; 9:108; PMID:18771576; http://dx.doi.org/10.1186/gb-2008-9-8-108
8. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell 2011; 147:44-56; PMID:21962506; http://dx.doi.org/10.1016/j.cell.2011.09.009
9. Glasner JD, Plunkett G 3rd, Anderson BD, Baumler DJ, Biehl BS, Burland V, Cabot EL, Darling AE, Mau B, Neeno-Eckwall EC, et al. Enteropathogen Resource Integration Center (ERIC): bioinformatics support for research on biodefense-relevant enterobacteria. [Database issue]. Nucleic Acids Res 2008; 36:D519-23; PMID:17999997; http://dx.doi.org/10.1093/nar/gkm973
10. Greene JM, Plunkett G Burland V, Glasner J, Cabot E, Anderson B, Neeno-Eckwall E, Qiu Y, Mau B, Rusch M, et al. A new asset for pathogen informatics--the Enteropathogen Resource Integration Center (ERIC), an NIAID Bioinformatics Resource Center for Biodefense and Emerging/ Re-emerging Infectious Disease. Adv Exp Med Biol 2007; 603:28-42; PMID:17966403; http://dx.doi.org/10.1007/978-0-387-72124-8_4
11. Drake RR, Deng Y, Schwegler EE, Gravenstein S. Proteomics for biodefense applications: progress and opportunities. Expert Rev Proteomics 2005; 2:203-13; PMID:15892565; http://dx.doi.org/10.1586/14789450.2.2.203
12. Rholl DA, Trunck LA, Schweizer HP. In vivo Himar1 transposon mutagenesis of Burkholderia pseudomallei. Appl Environ Microbiol 2008; 74:7529-35; PMID:18952878; http://dx.doi.org/10.1128/AEM.01973-08
13. Zogaj X, Klose KE. Genetic manipulation of francisella tularensis. Front Microbiol 2010; 1:142; PMID:21607086
14. Lu Q, Wei W, Kowalski PE, Chang AC, Cohen SN. EST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin. Proc Natl Acad Sci U S A 2004; 101:17246-51; PMID:15569923; http://dx.doi.org/10.1073/pnas.0407794101
15. Stundick MV, Albrecht MT, Houchens CR, Smith AP, Dreier TM, Larsen JC. Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule. Vet Pathol 2013; 50:877-92; PMID:23628693; http://dx.doi.org/10.1177/0300985813486812
16. Valdivia-Granda WA. Biosurveillance enterprise for operational awareness, a genomic-based approach for tracking pathogen virulence. Virulence 2013; 4; PMID:24152965; http://dx.doi.org/10.4161/viru.26893
17. Metzgar D, Sampath R, Rounds MA, Ecker DJ. The value and validation of broad spectrum biosensors for diagnosis and biodefense. Virulence 2013; 4; PMID:24128433; http://dx.doi.org/10.4161/viru.26652
18. Agren J, Hamidjaja RA, Hansen T, Ruuls R, Thierry S, Vigre H, Janse I, Sundström A, Segerman B, Koene M, et al. In silico and in vitro evaluation of PCR based assays for the detection of Bacillus anthracis chromosomal signature sequences. Virulence 2014; Forthcoming; PMID:24005110
19. Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence 2013; 4; PMID:23959032; http://dx.doi.org/10.4161/viru.23905
20. Walsh MJ, Dodd JE, Hautbergue GM. Ribosomeinactivating proteins: Potent poisons and molecular tools. Virulence 2013; 4; PMID:24071927; http://dx.doi.org/10.4161/viru.26399
21. Wright PR, Richter AS, Papenfort K, Mann M, Vogel J, Hess WR, Backofen R, Georg J. Comparative genomics boosts target prediction for bacterial small RNAs. Proc Natl Acad Sci U S A 2013; 110:E3487-96; PMID:23980183; http://dx.doi.org/10.1073/pnas.1303248110
22. Harris JF, Micheva-Viteva S, Li N, Hong-Geller E. Small RNA-mediated regulation of host-pathogen interactions. Virulence 2013; 4; PMID:23958954; http://dx.doi.org/10.4161/viru.26119
23. Vatansever F, Ferraresi C, de Sousa MV, Yin R, Rineh A, Sharma SK, Hamblin MR. Can biowarfare agents be defeated with light? Virulence 2013; 4; PMID:24067444; http://dx.doi.org/10.4161/viru.26475
24. Moreau GB, Mann BJ. Adherence and uptake of Francisella into host cells. Virulence 2013; 4; PMID:23921460; http://dx.doi.org/10.4161/viru.25629
25. van Hoek M. Biofilms: An advancement in our understanding of Francisella species. Virulence 2013; 4; http://dx.doi.org/10.4161/viru.27023
26. Thomas R. Particle size and pathogenicity in the respiratory tract. Virulence 2013; 4; http://dx.doi.org/10.4161/viru.27172
27. Skyberg JA. Immunotherapy for tularemia. Virulence 2013; 4; PMID:23959031; http://dx.doi.org/10.4161/viru.25454
28. Tegos GP, Hamblin MR. Disruptive innovations: new anti-infectives in the age of resistance. Curr Opin Pharmacol 2013; 13:673-7; PMID:24012294; http://dx.doi.org/10.1016/j.coph.2013.08.012